The U.S. Food and Drug Administration on Tuesday authorized a second booster dose of the two most commonly used COVID-19...
Articles by Michael Erman
Safety concerns about Johnson & Johnson’s COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout...
U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson’s COVID-19 vaccine for at least a few...
Drugmakers including Pfizer Inc., Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in...
Moderna Inc.’s COVID-19 vaccine appeared to be set for regulatory authorization this week after U.S. Food and Drug Administration staff...
A panel of outside advisers to the U.S. Food and Drug Administration is meeting on Thursday to weigh whether to...
Final results from Pfizer Inc.’s COVID-19 vaccine trial showed its shot had a 95% success rate and two months of...
Moderna Inc.’s experimental vaccine is 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company...
Johnson & Johnson was ordered on Thursday by a New Jersey state jury to pay punitive damages of $750 million...
Johnson & Johnson Chief Executive Alex Gorsky on Monday faced questions from plaintiffs lawyers over the timing of his sale...